Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,091 | -33,441 | -140,055 | -107,221 | -71,965 |
| Depreciation Amortization | 1,060 | 537 | 2,483 | 1,919 | 1,336 |
| Accounts receivable | N/A | N/A | 200 | 246 | 119 |
| Accounts payable and accrued liabilities | 3,829 | 2,818 | -3,301 | -2,472 | -953 |
| Other Working Capital | -7,686 | -8,990 | -7,614 | -5,899 | -2,476 |
| Other Operating Activity | 4,945 | 1,050 | 18,493 | 13,755 | 8,091 |
| Operating Cash Flow | $-67,943 | $-38,026 | $-129,794 | $-99,672 | $-65,848 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -28 | -28 | -21 |
| Investing Cash Flow | $0 | $0 | $-28 | $-28 | $-21 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 74,992 | 74,992 | 99,965 | 99,965 | 99,965 |
| Debt Repayment | N/A | N/A | -125 | -125 | -125 |
| Common Stock Issued | 2,075 | 471 | 1,606 | 352 | 0 |
| Financing Cash Flow | $77,067 | $75,463 | $101,446 | $100,192 | $99,840 |
| Beginning Cash Position | 124,220 | 124,220 | 152,596 | 152,596 | 152,596 |
| End Cash Position | 133,344 | 161,657 | 124,220 | 153,088 | 186,567 |
| Net Cash Flow | $9,124 | $37,437 | $-28,376 | $492 | $33,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,943 | -38,026 | -129,794 | -99,672 | -65,848 |
| Capital Expenditure | N/A | N/A | -31 | -31 | -21 |
| Free Cash Flow | -67,943 | -38,026 | -129,825 | -99,703 | -65,869 |